The bull wins on the operational trajectory, but the bear wins on valuation discipline — making Overweight the right call rather than full Buy or Underweight. On the bull side, the earnings inflection is mathematically compelling and visible: TTM EPS of $1.73 (depressed by ~$755M in one-time charges) transitioning toward consensus forward EPS of $3.12 implies an ~80% earnings rebound over the next 12 months. The Q3 FY26 print validates the trajectory — gross margin jumped 450bp sequentially to 24.6%, operating income rose to $1.2B from $802M, and free cash flow hit $1.35B in a single quarter. Net debt has declined $3B+ in just 9 months, and management has explicitly telegraphed buyback resumption once debt targets are met. The technical setup is constructive: price above all major moving averages ($108.49 vs. 50 SMA at $104.26 and 200 SMA at $95.84), MACD turning positive with fresh crossover, and RSI at 58.85 leaving room to run. Baird's $124 PT reflects normalized earnings, not fantasy. On the bear side, valuation discipline matters. 34.8x forward P/E sits at the upper end of SBUX's historical healthy-year range (25–30x), meaning the market is already pricing in successful execution of the "Back to Starbucks" playbook. The labor boycott called by Starbucks Workers United covering 12,000+ baristas is a genuine near-term risk during the PSL launch window, and we have zero comp data showing its impact. The China "strategic optionality" argument cuts both ways. The $22.4B debt load against negative book equity is a real constraint. And the macro backdrop (87% probability of zero Fed cuts in 2026, sticky inflation) compresses consumer discretionary multiples. The asymmetry: bull scenario targets $124+ (~15% upside) with extension to $130+ if buybacks resume or China action unlocks value; bear scenario requires both an earnings miss to ~$2.85 AND multiple compression to ~28x to hit the bear's ~$80 downside — a coordinated double-miss that has modest probability. The catalyst pipeline (Q4 earnings in late October/early November, buyback resumption guidance, China strategic action) creates multiple shots-on-goal for upside confirmation.

POSITION SIZING: Establish a starter position (~50% of target weight) at current levels near $108.49, with remaining capacity reserved for confirmation or better entry. The multiple is rich enough that we don't chase aggressively into upper Bollinger band resistance ($109.14).

SCALING RULES: Add on any pullback to the 50 SMA at $104.26 (the bull's own suggested stop zone, which doubles as a better risk-reward entry). A daily close below $100 invalidates the constructive thesis and warrants trimming to a neutral weight.

STOP DISCIPLINE: Hard stop at $99.50 (below the rising 200 SMA at $95.84 with buffer, and below recent consolidation lows). This caps downside at ~8% from current levels.

UPSIDE TARGETS: Primary target $124 (Baird PT) — scale out 25% of position. Secondary target $130+ if Q4 print confirms forward EPS trajectory toward $3.12+ or if buyback resumption is announced. Trail remaining position with the 20 SMA ($105.86 currently).

TIME HORIZON: 3–6 months. The setup resolves at Q4 FY26 earnings (late October/early November) — either the playbook is validated (forward EPS reaffirmed, margins held above 23%) or it's not. Avoid holding through the print with full size if we don't get pre-print confirmation.

KEY CATALYSTS TO MONITOR: (1) Q4 FY26 earnings print and forward guidance, (2) any labor boycott impact on weekly same-store sales data, (3) China strategic action announcement (sale/JV/franchise), (4) management commentary on buyback resumption timing, (5) PSL launch traffic reads.

HEDGE CONSIDERATION: At 34.8x forward with active boycott risk, a partial hedge via puts (Jan 2027 $100 strike) may be warranted if position size exceeds 3% of portfolio — the convexity is cheap given the multiple compression risk if Q4 disappoints.

The Overweight call rests on a compelling earnings inflection: TTM EPS of $1.73 (depressed by ~$755M in one-time charges) transitioning toward consensus forward EPS of $3.12 implies an ~80% rebound, validated by Q3 FY26's 450bp sequential gross margin expansion to 24.6% and $1.35B quarterly free cash flow. Technicals support gradual accumulation — price ($108.49) above the 50 SMA ($104.26) and 200 SMA ($95.84), MACD turning positive with fresh crossover, and RSI at 58.85 leaving runway. The 34.8x forward P/E is rich, but the asymmetry favors accumulation: bull case targets $124 (Baird PT) with extension to $130+ on buyback resumption, while bear case ($80) requires a coordinated double-miss (earnings to ~$2.85 AND multiple compression to ~28x) that has modest probability. A starter position now with scaling rules and a hard stop balances the favorable risk-reward against valuation discipline concerns.

Stop loss: $99.50

Sizing: Starter position at ~50% of target weight at current levels; reserve remaining capacity to add on pullback to 50 SMA at $104.26. Scale out 25% at $124 primary target, trail remaining with 20 SMA (~$105.86). Consider partial hedge via Jan 2027 $100 puts if position exceeds 3% of portfolio given active boycott risk.